119th Congress · House

HR. 2450

Prescription Drug Transparency and Affordability Act

committee
Introduced 2025-03-27•Latest 2025-03-27
Origin chamber
House
Cosponsors
3
Latest action
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Subjects
Health

Key actions

  1. 2025-03-27IntroReferral
    Introduced in House
  2. 2025-03-27IntroReferral
    Introduced in House
  3. 2025-03-27IntroReferral
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Bill text versions

Related bills

  • S. 891 (119) · Related bill
    Read twice and referred to the Committee on Finance.
  • HR. 1768 (119) · Related bill
    Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, the Budget, the Judiciary, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
← Back to Bills